Cargando…

Effects of Momordica charantia (Bitter Melon) on Ischemic Diabetic Myocardium

Objective: A rat model is here used to test a hypothesis that Momordica charantia (Bitter melon (BM)) extract favorably alters processes in cardiovascular tissue and is systemically relevant to the pathophysiology of type 2 diabetes (T2DM) and related cardiovascular disease. Methods: Male Lean and Z...

Descripción completa

Detalles Bibliográficos
Autores principales:	Czompa, Attila, Gyongyosi, Alexandra, Szoke, Kitti, Bak, Istvan, Csepanyi, Evelin, Haines, David D., Tosaki, Arpad, Lekli, Istvan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2017
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6155383/ https://www.ncbi.nlm.nih.gov/pubmed/28335529 http://dx.doi.org/10.3390/molecules22030488

Ejemplares similares

Beta-Carotene Affects the Effects of Heme Oxygenase-1 in Isolated, Ischemic/Reperfused Rat Hearts: Potential Role of the Iron
por: Csepanyi, Evelin, et al.
Publicado: (2022)

Aged (Black) versus Raw Garlic against Ischemia/Reperfusion-Induced Cardiac Complications
por: Czompa, Attila, et al.
Publicado: (2018)

The Effects of Long-Term, Low- and High-Dose Beta-Carotene Treatment in Zucker Diabetic Fatty Rats: The Role of HO-1
por: Csepanyi, Evelin, et al.
Publicado: (2018)

Rapamycin treatment increases survival, autophagy biomarkers and expression of the anti‐aging klotho protein in elderly mice
por: Szőke, Kitti, et al.
Publicado: (2023)

Postischemic cardiac recovery in heme oxygenase-1 transgenic ischemic/reperfused mouse myocardium
por: Juhasz, Bela, et al.
Publicado: (2011)

A case of atrial fibrillation due to Momordica charantia (bitter melon)
por: Erden, Ismail, et al.
Publicado: (2010)

Diverse roles of bitter melon (Momordica charantia) in prevention of oral cancer
por: Sur, Subhayan, et al.
Publicado: (2021)

Reduction of reperfusion-induced ventricular fibrillation and infarct size via heme oxygenase-1 overexpression in isolated mouse hearts
por: Bak, Istvan, et al.
Publicado: (2010)

Characterization of a Soluble Phosphatidic Acid Phosphatase in Bitter Melon (Momordica charantia)
por: Cao, Heping, et al.
Publicado: (2014)

Identification and Characterization of Phenylpropanoid Biosynthetic Genes and Their Accumulation in Bitter Melon (Momordica charantia)
por: Cuong, Do Manh, et al.
Publicado: (2018)

Bitter Melon (Momordica Charantia), a Nutraceutical Approach for Cancer Prevention and Therapy
por: Sur, Subhayan, et al.
Publicado: (2020)

Bitter Melon (Momordica charantia L.) Supplementation Has No Effect on Hypercholesterolemia and Atherosclerosis in Mice
por: Mohammadmoradi, Shayan, et al.
Publicado: (2020)

Dataset on structure, stability and myocardial effects of a new hybrid aspirin containing nitrogen monoxide-releasing molsidomine moiety
por: Szőke, Kitti, et al.
Publicado: (2019)

Momordica charantia (bitter melon) attenuates high-fat diet-associated oxidative stress and neuroinflammation
por: Nerurkar, Pratibha V, et al.
Publicado: (2011)

Momordica charantia (bitter melon) inhibits primary human adipocyte differentiation by modulating adipogenic genes
por: Nerurkar, Pratibha V, et al.
Publicado: (2010)

The Butanol Fraction of Bitter Melon (Momordica charantia) Scavenges Free Radicals and Attenuates Oxidative Stress
por: Kim, Hyun Young, et al.
Publicado: (2013)

Investigation of Biological Activities of Wild Bitter Melon (Momordica charantia Linn. Var. Abbreviata Ser.)
por: Pham, Thi My Hanh, et al.
Publicado: (2019)

Suppression of Inflammatory Cytokines Expression with Bitter Melon (Momordica Charantia) in TNBS-instigated Ulcerative Colitis
por: Semiz, Asli, et al.
Publicado: (2020)

Comparison of antioxidant capacities and antioxidant components of commercial bitter melon (Momordica charantia L.) products
por: AKYÜZ, Esin, et al.
Publicado: (2020)

Antioxidant Properties and Oxidative Transformation of Different Chromone Derivatives
por: Csepanyi, Evelin, et al.
Publicado: (2017)

Influence of Total Anthocyanins from Bitter Melon (Momordica charantia Linn.) as Antidiabetic and Radical Scavenging Agents
por: Güdr, Aytaç
Publicado: (2016)

Bitter Melon (Momordica charantia L.) Fruit Bioactives Charantin and Vicine Potential for Diabetes Prophylaxis and Treatment
por: , Mahwish, et al.
Publicado: (2021)

Comparative Pre-clinical Efficacy of Chinese and Indian Cultivars of Bitter Melon (Momordica charantia) against Pancreatic Cancer
por: Kandhari, Kushal, et al.
Publicado: (2021)

Bitter Melon (Momordica charantia L.) Rootstock Improves the Heat Tolerance of Cucumber by Regulating Photosynthetic and Antioxidant Defense Pathways
por: Tao, Mei-Qi, et al.
Publicado: (2020)

An Update Review on the Anthelmintic Activity of Bitter Gourd, Momordica charantia
por: Poolperm, Sutthaya, et al.
Publicado: (2017)

Analysis of the Complete Mitochondrial Genome of the Bitter Gourd (Momordica charantia)
por: Niu, Yu, et al.
Publicado: (2023)

Pharmacological Evaluation of Newly Synthesized Cannabidiol Derivates on H9c2 Cells
por: Szőke, Kitti, et al.
Publicado: (2023)

Strategies to improve palatability and increase consumption intentions for Momordica charantia (bitter melon): A vegetable commonly used for diabetes management
por: Snee, Laura S, et al.
Publicado: (2011)

Effects of Karela (Bitter Melon; Momordica charantia) on genes of lipids and carbohydrates metabolism in experimental hypercholesterolemia: biochemical, molecular and histopathological study
por: Saad, Dalia Yossri, et al.
Publicado: (2017)

Transcriptome and metabolome changes induced by bitter melon (Momordica charantia)- intake in a high-fat diet induced obesity model
por: Reed, Dominique, et al.
Publicado: (2021)

The Cardioprotective Effect of Metformin in Doxorubicin-Induced Cardiotoxicity: The Role of Autophagy
por: Zilinyi, Rita, et al.
Publicado: (2018)

Binding Energy calculation of GSK-3 protein of Human against some anti-diabetic compounds of Momordica charantia linn (Bitter melon)
por: Hazarika, Ridip, et al.
Publicado: (2012)

Correction: strategies to improve palatability and increase consumption intentions for Momordica charantia (bitter melon): a vegetable commonly used for diabetes management
por: Snee, Laura S, et al.
Publicado: (2014)

Momordica charantia (Bitter Melon) Reduces Obesity-Associated Macrophage and Mast Cell Infiltration as well as Inflammatory Cytokine Expression in Adipose Tissues
por: Bao, Bin, et al.
Publicado: (2013)

Bitter melon (Momordica charantia) attenuates atherosclerosis in apo-E knock-out mice possibly through reducing triglyceride and anti-inflammation
por: Zeng, Yanmei, et al.
Publicado: (2018)

Momordica charantia (bitter melon) efficacy and safety on glucose metabolism in Korean prediabetes participants: a 12-week, randomized clinical study
por: Kim, Bukyung, et al.
Publicado: (2022)

Electrically-Induced Ventricular Fibrillation Alters Cardiovascular Function and Expression of Apoptotic and Autophagic Proteins in Rat Hearts
por: Czegledi, Andras, et al.
Publicado: (2019)

The Role of Autophagy and Death Pathways in Dose-dependent Isoproterenol-induced Cardiotoxicity
por: Gyongyosi, Alexandra, et al.
Publicado: (2019)

Synthesis, In Vitro Biological Evaluation, and Oxidative Transformation of New Flavonol Derivatives: The Possible Role of the Phenyl-N,N-Dimethylamino Group
por: Szabados-Furjesi, Peter, et al.
Publicado: (2018)

Bitter Melon (Momordica charantia) Extract Inhibits Tumorigenicity and Overcomes Cisplatin-Resistance in Ovarian Cancer Cells Through Targeting AMPK Signaling Cascade
por: Yung, Mingo M. H., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_jq3rafap5gee0e0jon6kchtb9g